Tags: R&D
3D Printing Pen, BioPen, Will Enable Surgeons Draw Stem Cells Onto Patients' Bones and Joints Directly
BioPen uses 3D bioprinting technology to enable surgeons draw viable human stem cells in order to reconstruct bones of damaged joints. The product is still at the R&D stage and is still being actively tested and improved.
Chinese Venture Capital Firm Pando Group is Investing $2 Million in Israeli Fintech Hub The Floor
Israeli fintech hub initiative is receiving $2 million investments from Chinese venture capital firm Pando Group. The partnership is expected to build the bridge between Israel companies and the Asian markets.
Europe recession looks enduring, warns think tank
Europe recession looks enduring, warns the IPPR report. It said the severe unemployment and underemployment in Europe are signals of an alarming situation about the deepening recession.
Monsanto plans to close down three R&D centers in 2016, cutting out about 90 jobs
Missouri agrichemical giant Monsanto announced Monday that it will close down three research and development centers in 2016, cutting about 90 jobs. Reuters reported that the move is done to cut costs on its restructuring operations that are necessary for the dwindling agricultural commodity market.